IL211154A0 - Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel - Google Patents

Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel

Info

Publication number
IL211154A0
IL211154A0 IL211154A IL21115411A IL211154A0 IL 211154 A0 IL211154 A0 IL 211154A0 IL 211154 A IL211154 A IL 211154A IL 21115411 A IL21115411 A IL 21115411A IL 211154 A0 IL211154 A0 IL 211154A0
Authority
IL
Israel
Prior art keywords
assessing
markers
methods
ulcerative colitis
related disorders
Prior art date
Application number
IL211154A
Other languages
English (en)
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL211154(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Publication of IL211154A0 publication Critical patent/IL211154A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL211154A 2008-08-29 2011-02-10 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel IL211154A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9296608P 2008-08-29 2008-08-29
PCT/US2009/055323 WO2010025340A2 (en) 2008-08-29 2009-08-28 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel

Publications (1)

Publication Number Publication Date
IL211154A0 true IL211154A0 (en) 2011-04-28

Family

ID=41722298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL211154A IL211154A0 (en) 2008-08-29 2011-02-10 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel

Country Status (12)

Country Link
US (1) US20100069256A1 (enExample)
EP (1) EP2329259B1 (enExample)
JP (1) JP5586607B2 (enExample)
CN (1) CN102165315B (enExample)
AU (1) AU2009285644B2 (enExample)
BR (1) BRPI0917379A2 (enExample)
CA (1) CA2734519C (enExample)
DK (1) DK2329259T3 (enExample)
ES (1) ES2581774T3 (enExample)
IL (1) IL211154A0 (enExample)
RU (1) RU2011111748A (enExample)
WO (1) WO2010025340A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008028044A2 (en) * 2006-08-30 2008-03-06 Centocor, Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using 66 gene panel
WO2012154987A1 (en) 2011-05-10 2012-11-15 Nestec Sa Methods of disease activity profiling for personalized therapy management
WO2016063204A1 (en) * 2014-10-20 2016-04-28 Nestec S.A. Methods for prediction of anti-tnf alpha drug levels and autoantibody formation
WO2016092045A1 (en) * 2014-12-11 2016-06-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for predicting medically refractory acute severe colitis
GB2547406A (en) * 2015-11-20 2017-08-23 Folkersen Lasse Apparatus and methods of using of biomarkers for predicting TNF-inhibitor response
WO2017175228A1 (en) 2016-04-06 2017-10-12 Technion Research & Development Foundation Limited Infiltrating immune cell proportions predict anti-tnf response in colon biopsies
KR102481305B1 (ko) 2016-05-20 2022-12-26 세다르스-신나이 메디칼 센터 유전자에 기반한 염증성 장 질환의 진단
WO2017216206A1 (en) * 2016-06-14 2017-12-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting acute severe colitis treatment response
CA3064529C (en) 2017-05-31 2021-12-14 Prometheus Biosciences, Inc. Methods for assessing mucosal healing in crohn's disease patients
EP3821246A4 (en) * 2018-07-15 2022-06-22 Rambam Med-Tech Ltd. Determining responders to inflammation treatment
US20210355538A1 (en) * 2018-10-19 2021-11-18 Children's Hospital Medical Center Use of mucosal transcriptomes for assessing severity of ulcerative colitis and responsiveness to treatment
JP7657714B2 (ja) * 2018-11-15 2025-04-07 ヤンセン バイオテツク，インコーポレーテツド 炎症性腸疾患の治療に対する応答を予測するための方法及び組成物
CN114015689B (zh) * 2021-10-26 2024-06-07 江苏大学 一种特异性抑制GOS2基因表达的shRNA序列及其应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5721098A (en) 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JP3645903B2 (ja) 1992-03-04 2005-05-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 比較ゲノムハイブリダイゼーション（ｃｇｈ）
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
CA2174140C (en) 1993-10-28 2004-04-06 Kenneth L. Beattie Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5959098A (en) 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5723320A (en) 1995-08-29 1998-03-03 Dehlinger; Peter J. Position-addressable polynucleotide arrays
US5843655A (en) 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US6013440A (en) 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
AU3568897A (en) 1996-06-07 1998-01-05 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
ATE234674T1 (de) 1996-11-14 2003-04-15 Affymetrix Inc Chemische amplifizierung zur synthese von musterordnungen
WO1999009217A1 (en) 1997-08-15 1999-02-25 Hyseq, Inc. Methods and compositions for detection or quantification of nucleic acid species
US6197503B1 (en) 1997-11-26 2001-03-06 Ut-Battelle, Llc Integrated circuit biochip microsystem containing lens
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6087103A (en) 1998-03-04 2000-07-11 Lifespan Biosciences, Inc. Tagged ligand arrays for identifying target-ligand interactions
CA2323638A1 (en) 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6048695A (en) 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
US6093370A (en) 1998-06-11 2000-07-25 Hitachi, Ltd. Polynucleotide separation method and apparatus therefor
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US6174684B1 (en) 1999-08-11 2001-01-16 Trustees Of The University Of Pennsylvania CYP3A4 NFSE variant and methods of use therefore
EP1356088A2 (en) 2000-06-07 2003-10-29 Baylor College of Medicine Compositions and methods for array-based nucleic acid hybridization
US20040077020A1 (en) * 2001-11-30 2004-04-22 Mannick Elizabeth E. Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
JP2006504406A (ja) 2002-06-28 2006-02-09 セントカー・インコーポレーテツド 哺乳動物のｃｈ１欠失ミメティボディ、組成物、方法および使用
AU2005300688B2 (en) * 2004-11-03 2012-02-02 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
WO2007103823A2 (en) 2006-03-03 2007-09-13 University Of Southern California Genetic markers for predicting disease and treatment outcome
WO2008028044A2 (en) * 2006-08-30 2008-03-06 Centocor, Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using 66 gene panel
WO2008137383A2 (en) * 2007-04-30 2008-11-13 Centocor, Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using a 19 gene panel
EP2326731B1 (en) * 2008-08-25 2013-11-13 Janssen Biotech, Inc. Biomarkers for anti-tnf treatment in ulcerative colitis and related disorders

Also Published As

Publication number Publication date
EP2329259B1 (en) 2016-04-20
EP2329259A4 (en) 2012-05-16
CA2734519C (en) 2018-11-13
CN102165315A (zh) 2011-08-24
JP5586607B2 (ja) 2014-09-10
AU2009285644A1 (en) 2010-03-04
WO2010025340A3 (en) 2010-04-22
EP2329259A2 (en) 2011-06-08
RU2011111748A (ru) 2012-10-10
ES2581774T3 (es) 2016-09-07
AU2009285644B2 (en) 2015-08-20
CA2734519A1 (en) 2010-03-04
US20100069256A1 (en) 2010-03-18
BRPI0917379A2 (pt) 2015-11-17
DK2329259T3 (en) 2016-05-09
CN102165315B (zh) 2014-06-18
WO2010025340A2 (en) 2010-03-04
JP2012501452A (ja) 2012-01-19

Similar Documents

Publication Publication Date Title
IL211154A0 (en) Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
WO2008028044A9 (en) Markers and methods for assessing and treating ulcerative colitis and related disorders using 66 gene panel
IL211122A0 (en) Biomarkers for anti-tnf treatment in ulcerative colitis and related disorders
GB2459581B (en) Automated mse-based drilling apparatus and methods
IL233188A0 (en) Methods for evaluating rna patterns
EP2140442A4 (en) SYSTEMS AND METHOD FOR COMPUTER-BASED INTERACTIVE TRAINING
EP2162625A4 (en) DEVICES AND METHOD FOR ATTACHING A FASTENING ELEMENT
EP2029004A4 (en) EVALUATE DEMENTIA AND DEMENTIA-LIKE DISORDERS
EP2034896A4 (en) VISUALIZATION DEVICE AND METHOD FOR TRANSSEPTAL ACCESS
GB0702298D0 (en) Computer-implemented learning method and apparatus
EP2235179A4 (en) PROCESS FOR GENERATING AND IDENTIFYING FUNCTIONAL RNA INTERFERENCE ELEMENTS
ZA201001279B (en) Profiling method and apparatus
PL2371978T3 (pl) Blacha stalowa cienka i blacha stalowa cienka poddana obróbce powierzchni
TWI368551B (en) Vorrichtung und verfahren zum verbinden von baedern
IL199739A0 (en) Methods for treating psoriasis
EP2049691A4 (en) SUSCEPTIBILITY TREASURES FOR MORBUS CROHN
GB201001066D0 (en) Teaching and assessment methods and savings
PL2276578T3 (pl) Sposób i urządzenie do mocowania przegrody kierującej
PT2227612T (pt) Painel de revestimento e revestimento formado pelo mesmo
PL2253392T3 (pl) Urządzenie do walcowania na zimno i sposób stosowania takiego urządzenia do walcowania na zimno
GB0718499D0 (en) Keyboard practice apparatus
GB2464464B (en) Improved control and display arrangement for iron
EP2141705A4 (en) PLAYING DEVICE AND PROGRAM
TWI320435B (en) Verfahren zum herstellen einer kunststoff-wirkwerkzeugbarre und kunststoff-wirkwerkzeugbarre
GB2465088A8 (en) Methods for assessing RNA patterns